Acute Sore Throat Clinical Trial
Official title:
Phase IV Study Comparing the Efficacy and Safety of Benzydamine Hydrochloride 0,3% Oromucosal Spray and Benzydamine Hydrochloride 3 mg Lozenges in Patients With Acute Sore Throat
The aim of this study is to generate new clinical data about the speed of relief provided by a single application of Benzydamine hydrochloride 0,3% oromucosal spray vs Benzydamine hydrochloride 3 mg lozenges mint flavour.
The efficacy and safety of benzydamine local-applied, in the treatment of various throat inflammatory and painful conditions, had been widely demonstrated. The aim of this study is to generate new clinical data about the speed of relief provided by a single application of Benzydamine hydrochloride 0,3% oromucosal spray or Benzydamine hydrochloride 3 mg lozenges mint flavour. The study will be conducted at 15 sites located among Poland, Hungary and Russia (5 sites for each country). 356 patients affected by acute sore throat will be enrolled in out-patient clinics or out-patient departments of city hospitals. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01302769 -
Ear Acupuncture for Acute Sore Throat.
|
N/A | |
| Terminated |
NCT01301482 -
Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs)
|
N/A |